The Role of Pathology in the Era of Personalized (Precision) Medicine: A Brief Review
- PMID: 34075763
- DOI: 10.5644/ama2006-124.325
The Role of Pathology in the Era of Personalized (Precision) Medicine: A Brief Review
Abstract
This review provides a brief overview of the state-of-the-art molecular pathology approaches emphasizing the increasingly important pathology role in clinical precision cancer medicine. Recent advances in molecular biology and genetics have tremendously affected the practice of anatomic pathology, gradually transforming it from a morphology-based into a molecularbased discipline. Molecular diagnostics has a long tradition in pathology, especially in clinical pathology. The improvement of methodology for genomic testing in recent years has made it one of the cornerstones of precision cancer medicine. The decisions related to cancer treatments are no longer solely based on the histopathological diagnosis. Various genomic analyses of human cancers are being incorporated into diagnostic and decision-making algorithms. CONCLUSION: The pathologists continue to play an essential role in developing and implementing molecular and genomic tests in practice and communicate the results and their relevance with clinicians. Such activities are of utmost importance for successfully translating scientific advancements into a benefit to patients ("next-generation pathologists").
Keywords: Cancer Therapy; Companion Diagnostics; Diagnostics; Pathology; Precision Medicine.
Copyright © 2021 by Academy of Sciences and Arts of Bosnia and Herzegovina.
Similar articles
-
Personalized cancer medicine and the future of pathology.Virchows Arch. 2012 Jan;460(1):3-8. doi: 10.1007/s00428-011-1179-6. Epub 2011 Dec 6. Virchows Arch. 2012. PMID: 22143935 Review.
-
Precision diagnostics: integration of tissue pathology and genomics in cancer.Pathology. 2021 Dec;53(7):809-817. doi: 10.1016/j.pathol.2021.08.003. Epub 2021 Oct 8. Pathology. 2021. PMID: 34635323 Review.
-
The changing role of pathologists from morphologists to molecular pathologists in the era of precision medicine.Breast J. 2020 Jan;26(1):27-34. doi: 10.1111/tbj.13728. Epub 2019 Dec 25. Breast J. 2020. PMID: 31876097 Review.
-
[Molecular-Genetic Diagnosis and Molecular-Targeted Therapy in Cancer: Challenges in the Era of Precision Medicine].Rinsho Byori. 2015 Oct;63(10):1188-93. Rinsho Byori. 2015. PMID: 26897855 Review. Japanese.
-
[Molecular Pathology Diagnosis as Companion Diagnostics].Gan To Kagaku Ryoho. 2024 Apr;51(4):383-387. Gan To Kagaku Ryoho. 2024. PMID: 38644301 Japanese.
Cited by
-
Highlights from the 7th Oncological Pathology Conference 'Pathological Anatomy in the context of the National Cancer Law: An overview of the Latin American experience', 15, 22 and 23 July 2022, Trujillo, Peru.Ecancermedicalscience. 2022 Nov 2;16:1462. doi: 10.3332/ecancer.2022.1462. eCollection 2022. Ecancermedicalscience. 2022. PMID: 36819804 Free PMC article.
-
Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine Trial.J Pers Med. 2023 Jun 23;13(7):1033. doi: 10.3390/jpm13071033. J Pers Med. 2023. PMID: 37511646 Free PMC article.
-
Tissue management in precision medicine: What the pathologist needs to know in the molecular era.Front Mol Biosci. 2022 Oct 26;9:983102. doi: 10.3389/fmolb.2022.983102. eCollection 2022. Front Mol Biosci. 2022. PMID: 36387281 Free PMC article. Review.
-
Introducing AI to the molecular tumor board: one direction toward the establishment of precision medicine using large-scale cancer clinical and biological information.Exp Hematol Oncol. 2022 Oct 31;11(1):82. doi: 10.1186/s40164-022-00333-7. Exp Hematol Oncol. 2022. PMID: 36316731 Free PMC article. Review.
-
Tumor-Type Agnostic, Targeted Therapies: BRAF Inhibitors Join the Group.Acta Med Acad. 2022 Dec;51(3):217-231. doi: 10.5644/ama2006-124.392. Epub 2022 Dec 30. Acta Med Acad. 2022. PMID: 36799315 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
